Literature DB >> 19187258

Valacyclovir neurotoxicity: clinical experience and review of the literature.

T Asahi1, M Tsutsui, M Wakasugi, D Tange, C Takahashi, K Tokui, S Okazawa, H Okudera.   

Abstract

Valacyclovir (VACV) is used increasingly to treat herpes zoster, although neuropsychiatric symptoms [VACV neurotoxicity (VAN) or acyclovir neurotoxicity], may accompany use of this drug. To promote awareness of this rare condition, we describe here two clinical cases of VAN we previously reported and review 20 cases from the literature. In all cases, chronic or acute renal failure preceded VAN. The symptoms of VAN varied, but disturbances of consciousness and hallucination occurred most commonly. When acute renal failure was due to the drug, recovery from both the disturbance of consciousness and renal failure followed within several days after discontinuation of VACV. Early recognition and diagnosis will ensure effective treatment of VAN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187258     DOI: 10.1111/j.1468-1331.2008.02527.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  26 in total

1.  Case files of the Harvard medical toxicology fellowship: valacyclovir neurotoxicity and unintentional overdose.

Authors:  Colin Huguenel; Diana Felton; Rebecca Bruccoleri; Steven Salhanick
Journal:  J Med Toxicol       Date:  2015-03

Review 2.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

3.  Effect of high versus low oral doses of valacyclovir on herpes simplex virus-1 DNA shedding into tears of latently infected rabbits.

Authors:  Manish Kumar; Herbert E Kaufman; Christian Clement; Partha S Bhattacharjee; Tashfin S Huq; Emily D Varnell; Hilary W Thompson; James M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-14       Impact factor: 4.799

4.  Acute renal injury induced by valacyclovir hydrochloride: A case report.

Authors:  Yanning Zhang; Yuxi Cong; Yan Teng
Journal:  Exp Ther Med       Date:  2016-11-15       Impact factor: 2.447

Review 5.  Neuropsychiatric complications of chronic kidney disease.

Authors:  Rory McQuillan; Sarbjit V Jassal
Journal:  Nat Rev Nephrol       Date:  2010-06-22       Impact factor: 28.314

Review 6.  Resolution of acyclovir-associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature.

Authors:  W A Watson; N J Rhodes; I A Echenique; M P Angarone; M H Scheetz
Journal:  J Clin Pharm Ther       Date:  2017-03-29       Impact factor: 2.512

7.  Herpes zoster encephalopathy or acyclovir neurotoxicity: a management dilemma.

Authors:  Daniel Sacchetti; Aydah Alawadhi; Mustafa Albakour; Alwyn Rapose
Journal:  BMJ Case Rep       Date:  2014-04-28

Review 8.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

9.  Proteasome inhibition and its therapeutic potential in multiple myeloma.

Authors:  Ajai Chari; Amitabha Mazumder; Sundar Jagannath
Journal:  Biologics       Date:  2010-09-28

Review 10.  Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease.

Authors:  D P Devanand
Journal:  Curr Neurol Neurosci Rep       Date:  2018-07-14       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.